| 臺大學術典藏 |
2020-03-06T08:25:05Z |
Morphological subclassification of intrahepatic cholangiocarcinoma: Etiological, clinicopathological, and molecular features
|
Liau J.-Y.; Tsai J.-H.; Yuan R.-H.; Chang C.-N.; Lee H.-J.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:05Z |
TERT promoter mutation is uncommon in acral lentiginous melanoma
|
Liau J.-Y.; Tsai J.-H.; YUNG-MING JENG; Chu C.-Y.; Kuo K.-T.; Liang C.-W. |
| 臺大學術典藏 |
2020-03-06T08:25:04Z |
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis
|
Cheng Y.-C.; Cheng M.-L.; YUNG-MING JENG; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Lin L.-I. |
| 臺大學術典藏 |
2020-03-06T08:25:03Z |
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma
|
Yang C.-Y.;Liau J.-Y.;Huang W.-J.;Chang Y.-T.;Chang M.-C.;Lee J.-C.;Tsai J.-H.;Su Y.-N.;Hung C.-C.;Yung-Ming Jeng; Yang C.-Y.; Liau J.-Y.; Huang W.-J.; Chang Y.-T.; Chang M.-C.; Lee J.-C.; Tsai J.-H.; Su Y.-N.; Hung C.-C.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:02Z |
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
|
Liau J.-Y.;Tsai J.-H.;Yang C.-Y.;Lee J.-C.;Liang C.-W.;Hsu H.-H.;Yung-Ming Jeng; Liau J.-Y.; Tsai J.-H.; Yang C.-Y.; Lee J.-C.; Liang C.-W.; Hsu H.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:25:01Z |
Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome
|
Liau J.-Y.;Tsai J.-H.;Yung-Ming Jeng;Lee J.-C.;Hsu H.-H.;Yang C.-Y.; Liau J.-Y.; Tsai J.-H.; YUNG-MING JENG; Lee J.-C.; Hsu H.-H.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-06T08:25:01Z |
Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma
|
Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Liau J.-Y.;Yung-Ming Jeng; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; Liau J.-Y.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:24:59Z |
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
|
Lee J.-C.;Yung-Ming Jeng;Liau J.-Y.;Tsai J.-H.;Hsu H.-H.;Yang C.-Y.; Lee J.-C.; YUNG-MING JENG; Liau J.-Y.; Tsai J.-H.; Hsu H.-H.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-06T08:24:57Z |
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
|
YUNG-MING JENG; Ke Z.-L.; Hsu H.-H.; Liu T.-L.; Yang C.-Y.; Tsai J.-H.; Lee J.-C.; Liau J.-Y.; Liau J.-Y.;Lee J.-C.;Tsai J.-H.;Yang C.-Y.;Liu T.-L.;Ke Z.-L.;Hsu H.-H.;Yung-Ming Jeng |
| 臺大學術典藏 |
2020-03-06T08:24:56Z |
The diagnostic utility of PAX8 for neuroendocrine tumors: An immunohistochemical reappraisal
|
Liau J.-Y.; Tsai J.-H.; YUNG-MING JENG; Kuo K.-T.; Huang H.-Y.; Liang C.-W.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-06T08:24:56Z |
RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy
|
Tsai J.-H.; Liau J.-Y.; Yuan C.-T.; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:24:55Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai J.-H.;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Yung-Ming Jeng; Tsai J.-H.; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:24:53Z |
RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct
|
Tsai J.-H.;Liau J.-Y.;Yuan C.-T.;Cheng M.-L.;Yuan R.-H.;Yung-Ming Jeng; Tsai J.-H.; Liau J.-Y.; Yuan C.-T.; Cheng M.-L.; Yuan R.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:24:52Z |
Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma
|
Huang W.-J.;Tsai J.-H.;Yung-Ming Jeng; Huang W.-J.; Tsai J.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:24:50Z |
Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype
|
Huang W.-C.;Liau J.-Y.;Yung-Ming Jeng;Liu K.-L.;Lin C.-N.;Song H.-L.;Tsai J.-H.; Huang W.-C.; Liau J.-Y.; YUNG-MING JENG; Liu K.-L.; Lin C.-N.; Song H.-L.; Tsai J.-H. |
| 臺大學術典藏 |
2020-03-06T08:24:48Z |
Traditional Serrated Pathway-Associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations
|
Tsai J.-H.; YUNG-MING JENG; Yuan C.-T.; Lin Y.-L.; Cheng M.-L.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-06T08:24:47Z |
Correlation of molecular and morphological features of appendiceal epithelial neoplasms
|
Tsai J.H.; Yang C.-Y.; Yuan R.-H.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T08:24:46Z |
Targeted next-generation sequencing identifies distinct clinicopathologic and molecular entities of intraductal papillary neoplasms of the bile duct
|
Yang C.-Y.;Huang W.-J.;Tsai J.-H.;Cheng A.;Chen C.-C.;Hsu H.-P.;Yung-Ming Jeng; Yang C.-Y.; Huang W.-J.; Tsai J.-H.; Cheng A.; Chen C.-C.; Hsu H.-P.; YUNG-MING JENG |
| 臺大學術典藏 |
2020-03-06T05:26:15Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.; Liang Y.-H.; Tsai J.-H.; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-06T05:26:12Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; YIH-LEONG CHANG; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-06T05:26:09Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; YIH-LEONG CHANG; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:52:37Z |
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas
|
Chen Y.-L.; Jeng Y.-M.; Tsai J.-H.; Huang W.-C.; KUAN-TING KUO; Yuan R.-H. |
| 臺大學術典藏 |
2020-03-05T07:52:35Z |
Extraocular well-differentiated sebaceous tumors with overlying cutaneous horns: Four tumors in three patients
|
Jhuang J.-Y.; Liao S.-L.; Tsai J.-H.; Chang H.-C.; KUAN-TING KUO; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T07:52:35Z |
TERT promoter mutation is uncommon in acral lentiginous melanoma
|
Liau J.-Y.; Tsai J.-H.; Jeng Y.-M.; Chu C.-Y.; KUAN-TING KUO; Liang C.-W. |
| 臺大學術典藏 |
2020-03-05T07:52:35Z |
Frequent activating HRAS mutations in trichilemmoma
|
Tsai J.-H.; Huang W.-C.; Jhuang J.-Y.; Jeng Y.-M.; Cheng M.-L.; Chiu H.-Y.; KUAN-TING KUO; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:58Z |
Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcome
|
Yang C.-Y.; Hsu H.-H.; JEN-CHIEH LEE; Jeng Y.-M.; Tsai J.-H.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:58Z |
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
|
Liau J.-Y.; Tsai J.-H.; Yang C.-Y.; JEN-CHIEH LEE; Liang C.-W.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:38:58Z |
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma
|
Yang C.-Y.; Liau J.-Y.; Huang W.-J.; Chang Y.-T.; Chang M.-C.; JEN-CHIEH LEE; Tsai J.-H.; Su Y.-N.; Hung C.-C.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:38:57Z |
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
|
JEN-CHIEH LEE; Jeng Y.-M.; Liau J.-Y.; Tsai J.-H.; Hsu H.-H.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:57Z |
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
|
Liau J.-Y.; JEN-CHIEH LEE; Tsai J.-H.; Yang C.-Y.; Liu T.-L.; Ke Z.-L.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:38:55Z |
GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma
|
Huang H.-Y.; JEN-CHIEH LEE; Wang Y.-H.; Chen C.-C.; Lan J.; Tsai J.-H.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:38:53Z |
Thrombotic Hemangioma with Organizing/Anastomosing Features: Expanding the Spectrum of GNA -mutated Hemangiomas with a Predilection for the Skin of the Lower Abdominal Regions
|
Chung Y.-C.; Wang Y.-H.; Tsai J.-H.; Chen C.-C.; JEN-CHIEH LEE; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:28:42Z |
The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis-like T-cell lymphoma
|
Shih T.-F.; JAU-YU LIAU; Chuang S.-S.; Chu C.-Y.; Ku W.-H.; Tsai J.-H. |
| 臺大學術典藏 |
2020-03-05T06:28:41Z |
Frequent activating HRAS mutations in trichilemmoma
|
Tsai J.-H.;Huang W.-C.;Jhuang J.-Y.;Jeng Y.-M.;Cheng M.-L.;Chiu H.-Y.;Kuo K.-T.;Jau-Yu Liau; Tsai J.-H.; Huang W.-C.; Jhuang J.-Y.; Jeng Y.-M.; Cheng M.-L.; Chiu H.-Y.; Kuo K.-T.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:40Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:40Z |
Endocrine mucin-producing sweat gland carcinoma occurring on extra-facial site: A case report
|
Tsai J.-H.;Hsiao T.-L.;Chen Y.-Y.;Hsiao C.-H.;Jau-Yu Liau; Tsai J.-H.; Hsiao T.-L.; Chen Y.-Y.; Hsiao C.-H.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:40Z |
Morphological subclassification of intrahepatic cholangiocarcinoma: Etiological, clinicopathological, and molecular features
|
Jeng Y.-M.; Lee H.-J.; Chang C.-N.; Yuan R.-H.; Tsai J.-H.; JAU-YU LIAU; Jau-Yu Liau;Tsai J.-H.;Yuan R.-H.;Chang C.-N.;Lee H.-J.;Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:39Z |
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis
|
Tsai J.-H.;Jau-Yu Liau;Lin Y.-L.;Lin L.-I.;Cheng Y.-C.;Cheng M.-L.;Jeng Y.-M.; Tsai J.-H.; JAU-YU LIAU; Lin Y.-L.; Lin L.-I.; Cheng Y.-C.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:38Z |
Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas
|
Liang C.-W.; Hsu H.-H.; Jeng Y.-M.; Lee J.-C.; Yang C.-Y.; JAU-YU LIAU; Tsai J.-H.; Jau-Yu Liau;Tsai J.-H.;Yang C.-Y.;Lee J.-C.;Liang C.-W.;Hsu H.-H.;Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:38Z |
Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma
|
Hung C.-C.; Su Y.-N.; Tsai J.-H.; Lee J.-C.; Chang M.-C.; Chang Y.-T.; Huang W.-J.; JAU-YU LIAU; Yang C.-Y.; Yang C.-Y.;Jau-Yu Liau;Huang W.-J.;Chang Y.-T.;Chang M.-C.;Lee J.-C.;Tsai J.-H.;Su Y.-N.;Hung C.-C.;Jeng Y.-M.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:37Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-05T06:28:37Z |
Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma
|
Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Jau-Yu Liau;Jeng Y.-M.; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; JAU-YU LIAU; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:36Z |
Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas
|
Jau-Yu Liau;Lee J.-C.;Tsai J.-H.;Yang C.-Y.;Liu T.-L.;Ke Z.-L.;Hsu H.-H.;Jeng Y.-M.; JAU-YU LIAU; Lee J.-C.; Tsai J.-H.; Yang C.-Y.; Liu T.-L.; Ke Z.-L.; Hsu H.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:36Z |
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas
|
Lee J.-C.;Jeng Y.-M.;Jau-Yu Liau;Tsai J.-H.;Hsu H.-H.;Yang C.-Y.; Lee J.-C.; Jeng Y.-M.; JAU-YU LIAU; Tsai J.-H.; Hsu H.-H.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-05T06:28:34Z |
TERT promoter mutations in periocular carcinomas: Implications of ultraviolet light in pathogenesis
|
Lin S.-Y.;Liao S.-L.;Hong J.-B.;Chu C.-Y.;Sheen Y.-S.;Jhuang J.-Y.;Tsai J.-H.;Jau-Yu Liau; Lin S.-Y.; Liao S.-L.; Hong J.-B.; Chu C.-Y.; Sheen Y.-S.; Jhuang J.-Y.; Tsai J.-H.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:34Z |
RNF43 is an early and specific mutated gene in the serrated pathway, with increased frequency in traditional serrated adenoma and its associated malignancy
|
Tsai J.-H.; JAU-YU LIAU; Yuan C.-T.; Lin Y.-L.; Tseng L.-H.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:34Z |
The diagnostic utility of PAX8 for neuroendocrine tumors: An immunohistochemical reappraisal
|
Jau-Yu Liau;Tsai J.-H.;Jeng Y.-M.;Kuo K.-T.;Huang H.-Y.;Liang C.-W.;Yang C.-Y.; JAU-YU LIAU; Tsai J.-H.; Jeng Y.-M.; Kuo K.-T.; Huang H.-Y.; Liang C.-W.; Yang C.-Y. |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
Frequent PIK3CA-activating mutations in hidradenoma papilliferums
|
Jau-Yu Liau;Lan J.;Hong J.-B.;Tsai J.-H.;Kuo K.-T.;Chu C.-Y.;Sheen Y.-S.;Huang W.-C.; JAU-YU LIAU; Lan J.; Hong J.-B.; Tsai J.-H.; Kuo K.-T.; Chu C.-Y.; Sheen Y.-S.; Huang W.-C. |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions
|
Tsai J.-H.;Cheng C.-H.;Chen C.-C.;Lin Y.-L.;Lin L.-I.;Chen M.-L.;Jau-Yu Liau; Tsai J.-H.; Cheng C.-H.; Chen C.-C.; Lin Y.-L.; Lin L.-I.; Chen M.-L.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
